Kirby Institute

This project aims to make hepatitis C testing and treatment more accessible for people who visit drug treatment clinics and needle exchange programs. Researchers will work with 6,000 adults who have a history of injecting drug use to help them start treatment. The goal is to crea…

This study compares two FDA-approved drugs, moxidectin and ivermectin, to see which is better at reducing river blindness and other parasitic infections when given yearly to entire communities in Angola. Over 52,000 people will take part, and researchers will track infection rate…

This study looks at 320 adults who need strong immune-suppressing drugs and have already had at least two COVID-19 shots. Researchers want to find out if getting a booster right before starting treatment or waiting six months gives better protection. The goal is to help people wi…

This study aims to see if a simple finger-stick test can help more people get diagnosed and treated for hepatitis C. Researchers will test 60,000 adults at high risk, such as those in drug treatment clinics or prisons. Participants get tested once and fill out a survey, but do no…